PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytes

Osteoarthritis (OA) is an age‐related, chronic degenerative disease. With the increasing median age of the population, this disease has become an important public health problem. New, disease‐modifying therapies are needed. A potential novel molecular target is phospholipase Cγ1 (PLCγ1), a critical...

Full description

Bibliographic Details
Main Authors: Xiaolei Chen, Ri Chen, Yang Xu, Chun Xia
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:FEBS Open Bio
Subjects:
Online Access:https://doi.org/10.1002/2211-5463.13064
_version_ 1811206024980332544
author Xiaolei Chen
Ri Chen
Yang Xu
Chun Xia
author_facet Xiaolei Chen
Ri Chen
Yang Xu
Chun Xia
author_sort Xiaolei Chen
collection DOAJ
description Osteoarthritis (OA) is an age‐related, chronic degenerative disease. With the increasing median age of the population, this disease has become an important public health problem. New, disease‐modifying therapies are needed. A potential novel molecular target is phospholipase Cγ1 (PLCγ1), a critical enzyme with important functions including calcium signaling regulation and cell proliferation. In rat chondrocytes treated with IL‐1β (20 ng·mL−1 for 36 h), inhibition of PLCγ1 with U73122 (2 μm for 12 h) increased levels and expression of the cartilage matrix components Collagen2 and Aggrecan. This beneficial effect of PLCγ1 inhibition was counteracted by increased chondrocyte apoptosis and necroptosis, increased cell death, and increase levels of ROS, all potentially negative for OA. Combined treatment of IL‐1β + U73122‐treated chondrocytes with inhibitors of apoptosis (Z‐VAD, 10 μm) and necroptosis (Nec‐1, 30 μm) enhanced the increases in levels and expression of Collagen2 and Aggrecan, and prevented the increases in cell death and ROS levels. These results suggest that PLCγ1 inhibition may be a viable approach for an OA therapy, if combined with targeted inhibition of chondrocyte apoptosis and necroptosis.
first_indexed 2024-04-12T03:41:33Z
format Article
id doaj.art-eb6fa4467b9f4207a878828a6b8f5fb8
institution Directory Open Access Journal
issn 2211-5463
language English
last_indexed 2024-04-12T03:41:33Z
publishDate 2021-02-01
publisher Wiley
record_format Article
series FEBS Open Bio
spelling doaj.art-eb6fa4467b9f4207a878828a6b8f5fb82022-12-22T03:49:17ZengWileyFEBS Open Bio2211-54632021-02-0111243544510.1002/2211-5463.13064PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytesXiaolei Chen0Ri Chen1Yang Xu2Chun Xia3Zhongshan Hospital Xiamen University ChinaSchool of Medicine Xiamen University ChinaZhongshan Hospital Xiamen University ChinaZhongshan Hospital Xiamen University ChinaOsteoarthritis (OA) is an age‐related, chronic degenerative disease. With the increasing median age of the population, this disease has become an important public health problem. New, disease‐modifying therapies are needed. A potential novel molecular target is phospholipase Cγ1 (PLCγ1), a critical enzyme with important functions including calcium signaling regulation and cell proliferation. In rat chondrocytes treated with IL‐1β (20 ng·mL−1 for 36 h), inhibition of PLCγ1 with U73122 (2 μm for 12 h) increased levels and expression of the cartilage matrix components Collagen2 and Aggrecan. This beneficial effect of PLCγ1 inhibition was counteracted by increased chondrocyte apoptosis and necroptosis, increased cell death, and increase levels of ROS, all potentially negative for OA. Combined treatment of IL‐1β + U73122‐treated chondrocytes with inhibitors of apoptosis (Z‐VAD, 10 μm) and necroptosis (Nec‐1, 30 μm) enhanced the increases in levels and expression of Collagen2 and Aggrecan, and prevented the increases in cell death and ROS levels. These results suggest that PLCγ1 inhibition may be a viable approach for an OA therapy, if combined with targeted inhibition of chondrocyte apoptosis and necroptosis.https://doi.org/10.1002/2211-5463.13064apoptosisnecroptosisosteoarthritisPLCγ1U73122
spellingShingle Xiaolei Chen
Ri Chen
Yang Xu
Chun Xia
PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytes
FEBS Open Bio
apoptosis
necroptosis
osteoarthritis
PLCγ1
U73122
title PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytes
title_full PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytes
title_fullStr PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytes
title_full_unstemmed PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytes
title_short PLCγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in IL‐1β‐treated rat chondrocytes
title_sort plcγ1 inhibition combined with inhibition of apoptosis and necroptosis increases cartilage matrix synthesis in il 1β treated rat chondrocytes
topic apoptosis
necroptosis
osteoarthritis
PLCγ1
U73122
url https://doi.org/10.1002/2211-5463.13064
work_keys_str_mv AT xiaoleichen plcg1inhibitioncombinedwithinhibitionofapoptosisandnecroptosisincreasescartilagematrixsynthesisinil1btreatedratchondrocytes
AT richen plcg1inhibitioncombinedwithinhibitionofapoptosisandnecroptosisincreasescartilagematrixsynthesisinil1btreatedratchondrocytes
AT yangxu plcg1inhibitioncombinedwithinhibitionofapoptosisandnecroptosisincreasescartilagematrixsynthesisinil1btreatedratchondrocytes
AT chunxia plcg1inhibitioncombinedwithinhibitionofapoptosisandnecroptosisincreasescartilagematrixsynthesisinil1btreatedratchondrocytes